¥19.17 ($2.86)

+0.34 (+1.81%)

SHH · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 68 · ¥31.3B mcap · 1.19B float · 0.850% daily turnover

Revenue

$25.4B +3.7% ▲

5Y CAGR: +3.1%

Gross Profit

$11.3B +0.8% ▲

5Y CAGR: +5.6%

Operating Income

$2.5B -26.8% ▼

5Y CAGR: +6.5%

Net Income

$1.3B -37.7% ▼

5Y CAGR: +9.6%

EPS (Diluted)

$0.82 -37.4% ▼

5Y CAGR: +5.6%

EBITDA

$3.9B -5.7% ▼

5Y CAGR: +4.8%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$20.7B	$20.5B	$22.3B	$24.5B	$25.4B
YoY Growth	-5.2%	-0.6%	+8.7%	+9.8%	+3.7%
Cost of Revenue	$12.0B	$11.8B	$12.6B	$13.3B	$14.1B
Gross Profit	$8.7B	$8.8B	$9.7B	$11.2B	$11.3B
Gross Margin	41.9%	42.7%	43.5%	45.8%	44.5%
R&D Expenses	$768M	$810M	$967M	$1.5B	$1.5B
SG&A Expenses	$5.1B	$5.3B	$5.8B	$6.2B	$6.6B
Operating Expenses	$6.6B	$6.5B	$6.2B	$7.8B	$8.8B
Operating Income	$2.1B	$2.2B	$3.5B	$3.4B	$2.5B
Operating Margin	10.1%	10.9%	15.7%	14.1%	9.9%
Interest Expense	$868M	$624M	$504M	$409M	$380M
Income Before Tax	$2.0B	$2.2B	$3.4B	$3.4B	$2.4B
Tax Expense	$385M	$355M	$355M	$569M	$644M
Net Income	$1.0B	$1.3B	$2.5B	$2.1B	$1.3B
Net Margin	4.9%	6.4%	11.1%	8.7%	5.2%
EPS (Diluted)	$0.73	$0.82	$1.54	$1.31	$0.82
EBITDA	$3.3B	$3.0B	$3.4B	$4.1B	$3.9B
Shares Outstanding	1.38B	1.62B	1.61B	1.63B	1.62B

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$6.3B	$6.3B	$6.1B	$5.9B	$5.8B	$6.1B	$6.1B	$6.0B
Cost of Revenue	$3.3B	$3.9B	$3.2B	$3.1B	$3.1B	$3.1B	$3.1B	$3.1B
Gross Profit	$2.9B	$2.4B	$3.0B	$2.8B	$2.8B	$3.0B	$3.0B	$2.9B
Gross Margin	46.7%	37.5%	48.6%	47.6%	47.5%	49.0%	49.5%	48.6%
R&D Expenses	$387M	$377M	$409M	$335M	$307M	$450M	$359M	$255M
SG&A Expenses	$1.6B	$1.7B	$1.7B	$1.4B	$1.5B	-$799M	$1.6B	$1.4B
Operating Expenses	$2.1B	$2.5B	$2.1B	$1.8B	$1.8B	$2.5B	$2.1B	$1.8B
Operating Income	$836M	-$134M	$857M	$977M	$918M	$499M	$966M	$1.1B
Operating Margin	13.3%	-2.1%	14.0%	16.5%	15.8%	8.2%	15.8%	19.1%
Interest Expense	$91M	$81M	$81M	$74M	$60M	$57M	$53M	$56M
Income Before Tax	$814M	-$166M	$827M	$962M	$842M	$425M	$940M	$1.1B
Tax Expense	$162M	$163M	$129M	$163M	$156M	$115M	$170M	$135M
Net Income	$479M	-$260M	$540M	$614M	$534M	$167M	$588M	$741M
Net Margin	7.6%	-4.1%	8.8%	10.4%	9.2%	2.7%	9.6%	12.4%
EPS (Diluted)	$0.29	$-0.16	$0.33	$0.38	$0.33	$0.10	$0.36	$0.45
EBITDA	$1.2B	$312M	$1.1B	$1.2B	$883M	$745M	$993M	$1.4B
Shares Outstanding	1.63B	1.63B	1.64B	1.63B	1.63B	1.63B	1.63B	1.63B

600079.SS SHH